CASI Pharmaceuticals, Inc. (CASIF) Financials

CASIF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 21.1 million 79.3 million
March 31, 2026 21.1 million 79.3 million
Dec. 31, 2025 25.7 million 62.9 million
Sept. 30, 2025 24.5 million 53.1 million

CASIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 ? ?
Dec. 31, 2025 ? 3.0 million
Sept. 30, 2025 ? ?

CASIF Net Income

No data available :(

CASIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.8 million - -
March 31, 2026 3.8 million - -
Dec. 31, 2025 5.6 million - 1.4 million
Sept. 30, 2025 4.7 million - -

CASIF Shares Outstanding

No data available :(

CASIF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 1.2 million 10.9 million 3.8 million
March 31, 2026 - 1.2 million 10.9 million 3.8 million
Dec. 31, 2025 - 1.2 million 14.1 million 4.6 million
Sept. 30, 2025 - 1.4 million 9.5 million 4.6 million

CASIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 4.9 million 1.1 million
March 31, 2026 4.9 million 1.1 million
Dec. 31, 2025 7.2 million 3.5 million
Sept. 30, 2025 3.1 million 2.4 million

CASIF

Price: $0.10

52 week price:
0.05
2.13

Earnings Per Share: -3.02 USD

P/E Ratio: -0.05

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2.5 million

Links: